Lyell Immunopharma, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Lyell Immunopharma, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
Lyell Immunopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.55K %, a 13.6% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	1.55K	-245	-13.6%	Sep 30, 2024
Q2 2024	1.64K	-18.7	-1.13%	Jun 30, 2024
Q1 2024	1.67K	+137	+8.93%	Mar 31, 2024
Q4 2023	1.76K	+311	+21.4%	Dec 31, 2023
Q3 2023	1.8K	+436	+32%	Sep 30, 2023
Q2 2023	1.66K	+365	+28.2%	Jun 30, 2023
Q1 2023	1.54K	+247	+19.2%	Mar 31, 2023
Q4 2022	1.45K			Dec 31, 2022
Q3 2022	1.36K			Sep 30, 2022
Q2 2022	1.29K			Jun 30, 2022
Q1 2022	1.29K			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.